< Back to latest news & events

Awards

IAM Global Leaders 2020

January 2020

IAM has launched a new publication IAM Global Leaders. It features interviews with many of the world’s foremost private practice patent experts.

All the leaders listed as IAM Global Leaders merit special attention not only because of their expertise and experience relating to creating, protecting, managing, transacting and enforcing critical patent rights, but also for their ability to innovate, inspire, and go above and beyond to deliver for their clients.

The firm is delighted to announce that Partner Dr Gary Wilson has been listed in this ground-breaking publication.

IAM says: “Gary Wilson doesn’t just engage in patenting as an academic exercise – he is a commercial thinker whose advice goes to the heart of clients’ businesses and both their short and long-term objectives. Steeped in chemical, pharmaceutical and mechanical technologies, he demonstrates impressive industry range.”

Latest updates

Polymorphs: Clearing the Inventive Step Hurdle at the European Patent Office (EPO)

Polymorphic forms of active pharmaceutical ingredients (APIs) can represent commercially valuable compound subject matter and can be critical to providing necessary drug product characteristics and performance. However, patenting polymorphs is …

Read article

IQPC Global US Exchange

HGF are proud ‘Silver Plus’ sponsors of the IQPC Global US Exchange, at the Austin Marriot South, Texas. The IQPC Global US Exchange will be held at the Austin Marriot …

Read article

Update on the Precision Breeding Act 2023: details emerge of the new simplified regulatory pathway for gene edited plant and animal derived food and feed products

The Genetic Technology (Precision Breeding) Act 2023 could come into force as early as spring 2025. It empowers the Food Standards Agency (FSA) to create a new simplified regulatory pathway …

Read article

Court of Appeal Decision Upholds Invalidity of Patent Due to Amendment Identifying Embodiment as Outside the Scope of the Claims

In a case that highlights the challenges arising due to post-grant amendments, and in particular interpretation of the claims in view of the description, the Court of Appeal in Ensygnia …

Read article

UPC Court of Appeal clarifies approach for interpreting claims with “obvious” errors

Alexion Pharmaceuticals, Inc. v Samsung Bioepis NL B.V. [UPC_CoA_402/2024] –Court of Appeal of the UPC (Grabinski, Blok, Gougé, Enderlin, Hedberg) – 20 December 2024 Alexion Pharmaceuticals, Inc. v Amgen Technology …

Read article

IP Ingredients: Winter Case Law Review 2024

As the nights draw in and the frenzy to finish everything off before the holiday season reaches its peak, it’s time to take a break, grab your favourite hot beverage …

Read article